Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Mucommune Logo
Mucommune Growth Score
32
CB Rank
165167
Heat Score
72
Mucommune is a privately-held preclinical stage company launched based on the “muco-trapping” monoclonal antibodies (mAb) platform.
Founded
obfuscation
PrivateGrant Morrisville, North Carolina, United States1-10 www.mucommune.com/
Biotechnology
Pharmaceutical
Overview

Mucommune
Total Funding
obfuscation
Growth Score
32
Heat Score
72

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score32
-4 pts
in past quarter
Heat Score 72
-13 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Mucommune

CB Rank
165167
Mucommune is a privately-held preclinical stage company launched based on the “muco-trapping” monoclonal antibodies (mAb) platform.
Founded
obfuscation
PrivateGrant Morrisville, North Carolina, United States1-10 www.mucommune.com/
Biotechnology
Pharmaceutical

Funding Rounds

Grant
OBF
in
obfuscation

Key People

Details

Legal Name Mucommune, LLC
Operating Status Active
Company Type For Profit
Founders  Samuel Lai
About the Company
Mucommune is a privately-held preclinical stage company launched based on the “muco-trapping” monoclonal antibodies (mAb) platform developed at Johns Hopkins University and University of North Carolina at Chapel Hill.
Contact Email inquires@mucommune.com
Predictions & Insights

Products & Services

Muco-trapping monoclonal antibody platform
A technology platform that uses monoclonal antibodies to trap and immobilize pathogens, sperm, and other targets in mucus by harnessing Fc-mucin interactions.
Inhalon
A platform and company focused on inhaled muco-trapping monoclonal antibody therapies for treating acute respiratory infections.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Mucommune Logo
Grant - Mucommune
1
obfuscation
One North Carolina Small Business ProgramGrant
obfuscation
Grant - Mucommune Logo
Grant - Mucommune
1
obfuscation
One North Carolina Small Business ProgramGrant
obfuscation
Grant - Mucommune Logo
Grant - Mucommune
1
obfuscation
One North Carolina Small Business ProgramGrant
obfuscation
Grant - Mucommune Logo
Grant - Mucommune
1
obfuscation
One North Carolina Small Business ProgramGrant
obfuscation
Grant - Mucommune Logo
Grant - Mucommune
1
obfuscation
One North Carolina Small Business ProgramGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Mucommune Logo
Grant - Mucommune
1
obfuscation
One North Carolina Small Business ProgramGrant
obfuscation
Grant - Mucommune Logo
Grant - Mucommune
1
obfuscation
One North Carolina Small Business ProgramGrant
obfuscation
Grant - Mucommune Logo
Grant - Mucommune
1
obfuscation
One North Carolina Small Business ProgramGrant
obfuscation
Grant - Mucommune Logo
Grant - Mucommune
1
obfuscation
One North Carolina Small Business ProgramGrant
obfuscation
Grant - Mucommune Logo
Grant - Mucommune
1
obfuscation
One North Carolina Small Business ProgramGrant

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1 Contacts 1

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

310
-80.92%
 in past month

IT Spend

$404.6KThis year, Mucommune is projected to spend $404.6K on IT, according to Aberdeen.

Active Website Tech Count

3Mucommune is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is Mucommune's headquarters? Mucommune is located in Morrisville, North Carolina, United States.Who invested in Mucommune? Mucommune is funded by One North Carolina Small Business Program.When was the last funding round for Mucommune? Mucommune closed its last funding round on
obfuscation
from a Grant round.Who are Mucommune's competitors? Alternatives and possible competitors to Mucommune may include BIOMILQ, Lyndra Therapeutics, and  TMRW Life Sciences.How much funding has Mucommune raised to date? Mucommune has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(b82cf0e 1)
|